Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
Eva-Maria Hametner, Klaus Seppi, Werner PoeweDepartment of Neurology, Innsbruck Medical University, Innsbruck, AustriaAbstract: The aim of this article is to provide a short review of the most relevant pharmacological and clinical data on pramipexole extended release (ER) as well as to address the c...
Guardado en:
Autores principales: | Hametner EM, Seppi K, Poewe W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9824c32fbc7941e8b9b5342659a32ae5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Restless legs syndrome: differential diagnosis and management with pramipexole
por: Francesca Brindani, et al.
Publicado: (2009) -
Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
por: Werner Poewe, et al.
Publicado: (2010) -
Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors
por: Wang Q, et al.
Publicado: (2014) -
Psychosocial therapy for Parkinson's-related dementia: intervention development
por: McCormick SA, et al.
Publicado: (2017) -
A posturographic procedure assessing balance disorders in Parkinson's disease: a systematic review
por: Kamieniarz A, et al.
Publicado: (2018)